Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress'A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA approval for Phase 2 clinical trials earlier this month. He noted the "promise" of the ovarian cancer drug RC88. As ovarian cancer develops, the level of mesothelia increases — which gives RC88 its "unique" target, the RemeGen press release stated. Original article source: Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress'

Source: Fox News January 29, 2024 12:40 UTC